Autolus Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

Go back to Autolus Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

Autolus Therapeutics (AUTL) Misses Q3 EPS by 1c

November 2, 2023 7:13 AM EDT

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

... More